Department of Nephrology, Queensland Children's Hospital, Brisbane, Queensland, Australia.
Department of Medicine, Drexel University College of Medicine, Philadelphia, PA, USA.
Nat Rev Nephrol. 2024 Jul;20(7):473-485. doi: 10.1038/s41581-024-00820-6. Epub 2024 Apr 3.
Early detection is a key strategy to prevent kidney disease, its progression and related complications, but numerous studies show that awareness of kidney disease at the population level is low. Therefore, increasing knowledge and implementing sustainable solutions for early detection of kidney disease are public health priorities. Economic and epidemiological data underscore why kidney disease should be placed on the global public health agenda - kidney disease prevalence is increasing globally and it is now the seventh leading risk factor for mortality worldwide. Moreover, demographic trends, the obesity epidemic and the sequelae of climate change are all likely to increase kidney disease prevalence further, with serious implications for survival, quality of life and health care spending worldwide. Importantly, the burden of kidney disease is highest among historically disadvantaged populations that often have limited access to optimal kidney disease therapies, which greatly contributes to current socioeconomic disparities in health outcomes. This joint statement from the International Society of Nephrology, European Renal Association and American Society of Nephrology, supported by three other regional nephrology societies, advocates for the inclusion of kidney disease in the current WHO statement on major non-communicable disease drivers of premature mortality.
早期发现是预防肾脏疾病、其进展和相关并发症的关键策略,但许多研究表明,人群对肾脏疾病的认识程度较低。因此,提高对肾脏疾病的认识并实施可持续的早期检测解决方案是公共卫生的重点。经济和流行病学数据强调了为什么应该将肾脏疾病纳入全球公共卫生议程——全球范围内肾脏疾病的患病率正在上升,它现在是全球第七大导致死亡的风险因素。此外,人口趋势、肥胖流行和气候变化的后果都可能进一步增加肾脏疾病的患病率,对全球的生存、生活质量和医疗保健支出都产生严重影响。重要的是,肾脏疾病的负担在历史上处于不利地位的人群中最高,这些人群通常获得最佳肾脏疾病治疗的机会有限,这极大地导致了当前健康结果方面的社会经济差异。这份由国际肾脏病学会、欧洲肾脏协会和美国肾脏病学会联合发表的声明,得到了另外三个地区肾脏病学会的支持,主张将肾脏疾病纳入世界卫生组织目前关于导致过早死亡的主要非传染性疾病驱动因素的声明中。